Despite strong clinical data, RSV immunization rates among pregnant women and older adults remain worryingly low, ...

The CDC recently updated RSV vaccine recommendations to include certain adults aged 50 and up. When is the best time to get ...

The HHS is betting $500 million on developing a universal flu vaccine that could protect against multiple flu strains.

Parental trust in clinicians drove RSV vaccine uptake, while confusion and limited access to reliable information hindered ...

Appointments will continue to be issued over the next couple of weeks and pregnant women who are 28-week-plus are also ...

Sanofi acquires Vicebio for $1.15 billion, adding a next-gen RSV-hMPV vaccine and ‘Molecular Clamp' tech to strengthen its ...

Respiratory syncytial virus (RSV) poses a significant, often overlooked, risk for serious cardiovascular complications in ...

Winter is here, and with it come higher rates of respiratory illnesses. If you've been struck down recently with a sore ...

We may use terms like cold and the flu as if they are the same thing, but there are some key differences between them.

A single shot during pregnancy is proving to be a powerful shield for newborns against one of the most common and dangerous viruses for infants: RSV. In a new UK study, babies whose mothers received t ...

A new respiratory syncytial virus vaccine to protect infants from severe illness is available in South Africa’s private sector, but not yet in public clinics. The country’s advisory group on ...

The French pharma will pay $1.15 billion upfront to buy Vicebio and gain access to non-mRNA vaccine candidates against RSV ...